SCHEMBL8307610

SCHEMBL8307610

CCCCCOc1ccc(C=C2SC(=S)N(C)C2=O)cc1OC

nearest known ligand 0.80

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
MAPT P10636 7/20 0.80
PDE4B Q07343 3/20 0.59
MAPK1 P28482 2/20 0.58
KMT2A Q03164 5/20 0.57
MEN1 O00255 4/20 0.57
CTNNB1 P35222 2/20 0.56
TCF4 P15884 1/20 0.56
ALDH1A1 P00352 2/20 0.56
LMNA P02545 1/20 0.56
HTT P42858 1/20 0.56
AKR1B1 P15121 2/20 0.52
POLB P06746 2/20 0.52
PTPN1 P18031 1/20 0.52
CRHBP P24387 1/20 0.52
CRHR2 Q13324 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8308209 0.88 MAPT (0.61) MAPTPDE4BMAPK1KMT2AMEN1
SCHEMBL8310527 0.86 MAPT (0.59) MAPTPDE4BMAPK1KMT2AMEN1
SCHEMBL12008416 0.85 CTNNB1 (0.75) MAPTMAPK1KMT2AMEN1CTNNB1
SCHEMBL8713783 0.84 PDE4B (0.63) MAPTPDE4BMAPK1KMT2AMEN1
SCHEMBL12008497 0.84 CTNNB1 (0.73) MAPTMAPK1KMT2AMEN1CTNNB1
SCHEMBL12008421 0.84 CTNNB1 (0.73) MAPTMAPK1KMT2AMEN1CTNNB1
SCHEMBL12008513 0.83 CTNNB1 (0.81) MAPTMAPK1KMT2AMEN1CTNNB1
SCHEMBL541143 0.83 MAPT (0.89) MAPTPDE4BKMT2AMEN1ALDH1A1
SCHEMBL541142 0.83 MAPT (0.89) MAPTPDE4BKMT2AMEN1ALDH1A1
SCHEMBL19999085 0.83 MAPT (0.77) MAPTPDE4BMAPK1KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0915090-A1 Compounds useful as hypoglycemic agents and for treating Alzheimer's disease ELI LILLY AND COMPANY (US) 1999-05-12 EP disclosed
US-5716975-A NONTOXIC RHODANINE DERIVATIVES; ANTIDIABETIC AGENTS, CATHEPSIN D INHIBITORS, B-AMYLOID PROTEIN REDUCTION ELI LILLY AND COMPANY (US) 1998-02-10 US disclosed
US-5661168-A ADMINISTERING RHODANINE DERIVATIVES TO CONTROL DIABETES ELI LILLY AND COMPANY (US) 1997-08-26 US disclosed
US-5523314-A RHODANINE DERIVATIVES ELI LILLY AND COMPANY (US) 1996-06-04 US disclosed
EP-0587377-A2 Thiazolidinone derivatives as hypoglycemic agents and for treating Alzheimer's disease ELI LILLY AND COMPANY (US) 1994-03-16 EP disclosed